DiPT
N,N-diisopropyltryptamine
1Provenance card
the boundary, as counts
Sources
1913 with DOI
3 strong · 14 moderate · 2 weak
Compilations
12026-04-26T15:22:47.319Z
pipeline-v5 · prompt hash not recorded — run predates 2026-09
Decisions
40last ruled 2026-06-04
0 awaiting a ruling
Issued documents
62026-10-19T20:31:34.918Z
notice · info card · emergency
Searches
181 with no results
queries and counts on the build
Claims checked
5735 supported
35 supported · 22 not
Correspondence
0received
consent field ships in Phase 4
Edges
208
derivations recorded for this entity
Complete over 19 sources, 1 compilation, and 40 decisions.Not here: the private journal (never).Working material — drafts, discards, unsupported claims — is listed below and readable on the working page.Cite: psychedex.org/substances/dipt/archive
Timeline
what happened, newest first — claims, searches and artifacts stay inside Build
- 2026-10-19issueIssued emergency
- 2026-10-19issueIssued info_card
- 2026-10-19issueIssued notice
- 2026-09-24srcDiscriminative stimulus effects of N,N-diisopropyltryptamine
- 2026-09-24srcInteraction of psychoactive tryptamines with biogenic amine transporters and serotonin receptor subtypes.
- 2026-09-24srcSerotonin toxicity of serotonergic psychedelics
- 2026-09-24srcTolerance and Cross-Tolerance among Psychedelic and Nonpsychedelic 5-HT2A Receptor Agonists in Mice
- 2026-09-24srcRE104: Synthesis and Activity of a Novel Serotonergic Psychedelic Prodrug of 4-Hydroxy-N,N-diisopropyltryptamine
- 2026-09-24srcDiscriminative Stimulus Effects of Substituted Tryptamines in Rats
- 2026-09-24srcN,N-Diisopropyltryptamine and diptogenia: proposed mechanisms for a frequency-selective pitch-distorting psychedelic
- 2026-09-24srcSafety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneous RE104: A Double-Blind, Randomized, Single Ascending Dose Placebo-Controlled Study
- 2026-09-24srcPsychedelics
- 2026-09-24srcIndolealkylamines: biotransformations and potential drug-drug interactions
- 2026-09-24srcRecreational use, analysis and toxicity of tryptamines.
- 2026-09-24srcSerotonergic hyperactivity as a potential factor in developmental, acquired and drug-induced synesthesia
- 2026-09-24srcToxicology and Analysis of Psychoactive Tryptamines.
- 2026-09-24srcRhabdomyolysis after ingestion of 'foxy,' a hallucinogenic tryptamine derivative
- 2026-09-24srcHallucinogen-like effects of N,N-dipropyltryptamine (DPT): possible mediation by serotonin 5-HT1A and 5-HT2A receptors in rodents.
- 2026-09-24srcLysergic acid diethylamide (LSD) administration selectively downregulates serotonin2 receptors in rat brain
- 2026-09-24srcDifferential interactions of indolealkylamines with 5-hydroxytryptamine receptor subtypes
- 2026-09-24srcN,N-Diisopropyltryptamine (DIPT) and 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT). Two orally active tryptamine analogs with CNS activity.
- 2026-09-24srcErowid DiPT Vault - TiHKAL Entry #4
- 2026-09-04issueIssued emergency
- 2026-09-04issueIssued info_card
- 2026-09-04issueIssued notice
- 2026-06-04proposal38 value proposals approved togetherone review action inferred from a shared reviewer and instant — the graph records one activity per proposal
- 2026-06-04publicationPublication — backfill
- 2026-04-26revisionRevision 1
- 2026-04-26absenceSearched ClinicalTrials.gov for "diisopropyltryptamine DiPT" — no results
- 2026-04-26genGeneration — pipeline-v5pipeline-v5
- 2026-04-26rungeneration run
The same entries, as forms: six forms.